Quantitative Analysis of Antibiotic Use in Acute Respiratory Tract Infection Patients Using ATC/DDD and DU90% Methods at Bulango Health Center, Bone Bolango Regency, January–December 2025
Article metrics
OJS usage and citation sourcesViews and downloads are recorded by OJS; statistics processing may be delayed. A dash means the source count is unavailable. Search Google Scholar
Article Sidebar
Mohamad Rizaldy Hiola, Misgiati, Nanang Ardianto, Prisca Safriani Wicita (2026). Quantitative Analysis of Antibiotic Use in Acute Respiratory Tract Infection Patients Using ATC/DDD and DU90% Methods at Bulango Health Center, Bone Bolango Regency, January–December 2025. Journal of Pharmaceutical and Sciences, JPS Volume 9 Nomor 3 (2026). https://doi.org/10.36490/journal-jps.com.v9i3.1638
Main Article Content
Abstract
settings and a major driver of antimicrobial resistance (AMR). This study aimed to evaluate the quantitative pattern of antibiotic use in ARTI patients at Bulango Health Center, Bone Bolango Regency, during January–December 2025, using the Anatomical Therapeutic Chemical/Defined Daily Dose (ATC/DDD) and Drug Utilization 90% (DU90%) methods. A descriptive observational retrospective study was conducted on 179 samples using the ATC/DDD and DU90% methods. Five antibiotics were identified: cefadroxil (J01DB05), amoxicillin (J01CA04), cotrimoxazole (J01EE01), ciprofloxacin (J01MA02), and metronidazole (P01AB01). Total antibiotic consumption was 356.7 DDD. Cefadroxil had the highest consumption at 210.9 DDD (3.23 DDD/1000 patient-days; 59.13%), followed by amoxicillin at 132.2 DDD (2.02 DDD/1000 patient-days; 37.06%). DU90% analysis identified cefadroxil and amoxicillin as the antibiotics within the DU90% segment, with a cumulative percentage of 96.2%. Cefadroxil dominance over amoxicillin is inconsistent with national therapeutic guidelines recommending amoxicillin as first-line therapy for ARTI. These findings emphasize the need for an Antimicrobial Stewardship Program (ASP) at the primary health care level
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
How to Cite
References
WHO. Pencegahan dan Pengendalian Infeksi Saluran Pernapasan Akut (ISPA) yang Cenderung Menjadi Epidemi dan Pandemi di Fasilitas Pelayanan Kesehatan. 2020.
Sauriasari R, Azka A, Aulia H, Swastika A. Evaluasi kesesuaian penulisan resep pada kasus ISPA non pneumonia di poli MTBS Puskesmas Kecamatan Cengkareng , Jakarta The evaluation of prescription conformity on non-pneumonia Cengkareng District Community Health Centre , Jakarta Abstrak 2017;4.
Kemenkes RI. Profil Kesehatan. 2024.
Azzahra L, Toka W Do, Husen AH, Yati S, Kedokteran F, Biomedik BI, et al. Hubungan Penggunaan Antibiotik dengan Kekambuhan Infeksi Saluran Pernapasan Akut pada Balita di Layanan Primer Kota Ternate 1 2023;24:377–81.
WHO. Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report 2024. 2024.
Mambo CD, Masengi ASR, Thomas DA, Studi P, Dokter P, Kedokteran F, et al. Rasionalitas Penggunaan Antibiotik untuk Pengobatan Infeksi Saluran Pernapasan Akut pada Anak 2024;6:72–9. https://doi.org/10.35790/msj.v6i1.45431.
Nurawaliah CM, Hilmi I laily, Salman. Rasionalitas penggunaan obat antibiotik pada pasien ispa di beberapa puskesmas di indonesia: studi literatur. J Farmasetis 2023;12:129–38. https://doi.org/10.32583/far.v12i2.723.
WHO. Global antimicrobial resistance and use surveillance system (GLASS) report 2024. 2024.
Argirova R, Zlatareva A. Antimicrobial resistance – causes , threats , solutions 2022.
Vidiani A, Aswara L, Adrianto M, Kharisma W. Evaluasi peresepan antibiotik pada pasien ISPA pediatri menggunakan metode ATC/DDD. J Kesehat Amanah 2023;7:120–8.
Karimi G, Kabir K, Farrokhi B, Abbaszadeh E, Esmaeili ED. Prescribing pattern of antibiotics by family physicians in primary health care. J Pharm Policy Pract 2023;16:1–9. https://doi.org/10.1186/s40545-023-00515-6.
Pani S, Barliana M, Halimah E, Pradipta I. Monitoring penggunaan antibiotik dengan metode ATC/DDD dan DU90% di seluruh puskesmas Kabupaten Gorontalo Utara. Indones J Clin Pharmacy 2017;6:289–98.
Pratama S, Andriani Y, Habibie M. Evaluasi penggunaan antibiotik berdasarkan metode ATC/DDD dan DU90% di Puskesmas Koni dan Tanjung Pinang Kota Jambi tahun 2017–2018. Inf Promosi Kesehat 2019;1:45–53.
WHO, Centre for Drug Statistics Methodology. The ATC/DDD Methodology. 2024.
WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2026 2026.
Kemenkes RI. Pedoman Pengendalian Infeksi Saluran Pernapasan Akut. Jakarta: 2022.
Katzung, Trevor AJ. Basic & Clinical Pharmacology (16th ed.). McGraw-Hill Education; 2024.
Kemenkes RI. Pedoman Pencegahan dan Pengendalian ISPA. 2022.
WHO. WHO AWaRe classification of antibiotics for evaluation and monitoring of use. 2022.
Sinata N, Regika D, Febrina M. Evaluation Of Antibiotic Use Using The ATC / DDD And Du90 % Methods In Outpatient Patients In Puskesmas Ri Tenayan Raya. Med Sains J Ilm Kefarmasian Vol 2024;9:277–90.
Kemenkes RI. Pedoman Penggunaan Antibiotik. Peraturan Menteri Kesehatan RI Nomor 28 Tahun 2021. Jakarta: 2021.
Bergman U et al. “Drug utilization 90%—a simple method for assessing the quality of drug prescribing”, European Journal of Clinical Pharmacology. , Eur J Clin Pharmacol 1998;54:113–8. https://doi.org/10.1007/s002280050431.
Effendi F, Evelin A, Studi P, Sekolah F, Teknologi T, Bogor F. Evaluasi Penggunaan Antibiotik Pasien Infeksi Saluran Pernafasan Akut (ISPA) Dengan MetodeATC/DDD Di Puskesmas Beji Depok Periode Januari-Juni 2019. J Farmamedika 2020;5:8–13.
Sari, O M, Intannia D, Lingga HN, Sandi, D. A. D Setiawan D, Andini RS, Dania SR. Analysis of antibiotic use with the ATC/DDD and DU 90% methods at the Banjarbaru Selatan Health Center in 2023–2024. J Ilm Medicam 2025;11. https://doi.org/https://doi.org/10.36733/medicamento.v11i2.11811.
Pitasari N, Imba F, Litaay GW. Indonesian Journal of Global Health Research. Indones J Glob Heal Res 2025;7:1023–30.
Hooper DC, Jacoby GA. Mechanisms of action and resistance of older and newer fluoroquinolones. Clin Infect Dis 2015;41:24–8.
Goodman & Gilman. Goodman & Gilman’s The Pharmacological Basis of Therapeutics 14 th ed. McGraw-Hill Education; 2023.
Sitepu R, Cahyono T., Monica E. Evaluasi penggunaan antibiotik dengan metode ATC/DDD dan DU90% pada penderita ISPA non-pneumonia di Puskesmas Kab. Sampang. J JKFT (Jurnal Kefarmasian Dan Farm Ter 2020.
Andriani Y, Meirista I, Aprio Y. Evaluasi Penggunaan Antibiotik Dengan Metode ATC / DDD Dan DU 90 % Di Puskesmas Kebun Handil Kota Jambi Periode 2018 dan 2019. J Healthc Technol Med Vol 2020;6:700–7.
Bush K, Bradford PA. Epidemiology of β-lactamase-producing pathogens. Clin Microbiol Rev 2020;22. https://doi.org/https://doi.org/10.1128/CMR.00047-19.
IDSA. Infectious Diseases Society of America: Clinical Practice Guidelines for the Diagnosis and Treatment of Adults with Community-Acquired Pneumonia. Arlington :IDSA: 2022.
Charani E, E C-S, Holmes A. The role of behavior change in antimicrobial stewardship. Infect Dis Clin North Americ 2019;28:169–75.
WHO. AWaRe Classification of Antibiotics for Evaluation and Monitoring of Use 2023.
O’Neill J. Tackling drug-resistant infections globally. Rev Antimicrob Resist 2016.
Limato R, Lazarus G, Dernison P. Optimizing antibiotic use in Indonesia: A systematic review and evidence synthesis to inform opportunities for intervention. Lancet Reg Heal – Southeast Asia 2022;2. https://doi.org/https://doi.org/10.1016/j.lansea.2022.05.002.
Guide S. The Sanford Guide to Antimicrobial Therapy 54th ed. Sperryville: Antimicrobial Therapy, Inc; 2024.
Mandell, Douglas, Bennett. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 9th ed. Philadelphia, US: Elsevier; 2020.
WHO. WHO AwaRe classification of antibiotics for evaluation and monitoring of use. 2023.